David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Artivion
AORT
$1.33B
| $1.82M | ﹤0.01% |
101,603
+34,985
| +53% | +$544K |
|
2602
UDR
UDR
$12.2B
| $1.81M | ﹤0.01% |
47,198
-36,596
| -44% | -$1.27M |
|
|
CIO
2603
DELISTED
City Office REIT
CIO
| $1.8M | ﹤0.01% |
295,249
+82,074
| +39% | +$383K |
|
2604
CALL
PG&E
PCG
$40.1B
| $1.8M | ﹤0.01% |
100,000
| – | – |
|
2605
CALL
Royal Gold
RGLD
$22.5B
| $1.8M | ﹤0.01% |
14,900
| – | – |
|
|
LTHM
2606
PUT
DELISTED
Livent Corporation
LTHM
| $1.8M | ﹤0.01% |
+100,200
| New | +$1.56M |
|
2607
PUT
Camping World
CWH
$672M
| $1.8M | ﹤0.01% |
68,600
+8,600
| +14% | +$180K |
|
2608
CALL
Enovix
ENVX
$746M
| $1.79M | ﹤0.01% |
163,657
-102,400
| -38% | -$1.01M |
|
2609
Scholar Rock
SRRK
$7.31B
| $1.79M | ﹤0.01% |
95,291
+26,469
| +38% | +$329K |
|
2610
EQT Corp
EQT
$34.3B
| $1.79M | ﹤0.01% |
46,276
-127,082
| -73% | -$5.15M |
|
2611
CALL
Dave & Buster's
PLAY
$343M
| $1.79M | ﹤0.01% |
33,200
+600
| +2% | +$24.3K |
|
2612
CALL
MGM Resorts International
MGM
$10.9B
| $1.79M | ﹤0.01% |
40,000
-94,600
| -70% | -$3.71M |
|
2613
CALL
Cboe Global Markets
CBOE
$32.6B
| $1.79M | ﹤0.01% |
+10,000
| New | +$1.71M |
|
2614
Perion Network
PERI
$374M
| $1.79M | ﹤0.01% |
57,833
-2,363
| -4% | -$67.1K |
|
2615
Wynn Resorts
WYNN
$10B
| $1.78M | ﹤0.01% |
19,550
-188,089
| -91% | -$16.7M |
|
|
ITOS
2616
DELISTED
iTeos Therapeutics
ITOS
| $1.77M | ﹤0.01% |
162,058
+47,600
| +42% | +$472K |
|
2617
YPF Sociedad Anonima ADS
YPF
$19.7B
| $1.77M | ﹤0.01% |
103,224
+75,494
| +272% | +$1.04M |
|
2618
PUT
Thor Industries
THO
$4.05B
| $1.77M | ﹤0.01% |
15,000
| – | – |
|
2619
GeoPark
GPRK
$630M
| $1.77M | ﹤0.01% |
206,559
-43,392
| -17% | -$410K |
|
|
ZYXI
2620
DELISTED
Zynex
ZYXI
| $1.77M | ﹤0.01% |
162,296
+98,849
| +156% | +$880K |
|
2621
PUT
Bunge Global
BG
$21.8B
| $1.77M | ﹤0.01% |
17,500
-43,800
| -71% | -$4.59M |
|
|
APLS
2622
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $1.77M | ﹤0.01% |
29,500
| – | – |
|
2623
CALL
Chubb
CB
$133B
| $1.76M | ﹤0.01% |
7,800
-2,200
| -22% | -$481K |
|
2624
Cimpress
CMPR
$2.12B
| $1.76M | ﹤0.01% |
21,978
+4,205
| +24% | +$293K |
|
2625
Titan International
TWI
$455M
| $1.76M | ﹤0.01% |
118,178
+24,580
| +26% | +$324K |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.